HomepageBIOG-B • STO
add
BioGaia AB
Vorige slotkoers
kr 120,00
Dag-range
kr 120,00 - kr 121,60
Jaar-range
kr 93,20 - kr 122,10
Beurswaarde
11,82Â mld. SEK
Gem. volume
221,77K
Koers/winst
-
Dividendrendement
-
Primaire beurs
STO
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (SEK) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 440,57Â mln. | 20,76% |
Bedrijfskosten | 196,47Â mln. | 69,09% |
Netto inkomsten | 98,78Â mln. | 20,56% |
Netto winstmarge | 22,42 | -0,18% |
Winst per aandeel | 0,98 | — |
EBITDA | 133,49Â mln. | -10,77% |
Effectief belastingtarief | 20,07% | — |
Balans
Totale activa
Totale passiva
| (SEK) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 801,31Â mln. | -34,53% |
Totale activa | 1,60Â mld. | -21,45% |
Totale passiva | 283,59Â mln. | -8,54% |
Totaal aandelenvermogen | 1,31 mld. | — |
Uitstaande aandelen | 101,16 mln. | — |
Koers-boekwaardeverhouding | 9,24 | — |
Rendement op activa | 20,64% | — |
Rendement op kapitaal | 24,92% | — |
Kasstroom
Nettomutatie in liquide middelen
| (SEK) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 98,78Â mln. | 20,56% |
Operationele kasstroom | 83,52Â mln. | -18,23% |
Kasstroom uit beleggingen | -452,00K | -79,37% |
Kasstroom uit financiering | -6,61Â mln. | -160,38% |
Nettomutatie in liquide middelen | 73,21Â mln. | -33,07% |
Vrije kasstroom | 53,30Â mln. | 13,33% |
Over
BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis. Their oral health products contain L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. Wikipedia
Opgericht
1990
Website
Werknemers
242
